Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Self-Induced Diffusion in Disordered Nonlinear Photonic Media.

Sharabi Y, Herzig Sheinfux H, Sagi Y, Eisenstein G, Segev M.

Phys Rev Lett. 2018 Dec 7;121(23):233901. doi: 10.1103/PhysRevLett.121.233901.

PMID:
30576211
2.

3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine.

Jinsmaa Y, Sharabi Y, Sullivan P, Isonaka R, Goldstein DS.

J Pharmacol Exp Ther. 2018 Jul;366(1):113-124. doi: 10.1124/jpet.118.248492. Epub 2018 Apr 26.

3.

Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease.

Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y.

Parkinsonism Relat Disord. 2018 May;50:108-112. doi: 10.1016/j.parkreldis.2018.02.023. Epub 2018 Feb 15.

PMID:
29475591
4.

Ambulatory blood pressure profiles in familial dysautonomia.

Goldberg L, Bar-Aluma BE, Krauthammer A, Efrati O, Sharabi Y.

Clin Auton Res. 2018 Aug;28(4):385-390. doi: 10.1007/s10286-018-0507-1. Epub 2018 Feb 12.

PMID:
29435868
5.

Clinical Problem Solving: A Tobacco Merchant Who Can't Spit.

Benizri S, Agmon-Levin N, Kitrey ND, Carter D, Goshen E, Sharabi Y.

Isr Med Assoc J. 2017 Dec;19(12):786-791.

6.

Cardiac sympathetic denervation predicts PD in at-risk individuals.

Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y.

Parkinsonism Relat Disord. 2018 Jul;52:90-93. doi: 10.1016/j.parkreldis.2017.10.003. Epub 2017 Oct 5.

PMID:
29032895
7.

The heart of PD: Lewy body diseases as neurocardiologic disorders.

Goldstein DS, Sharabi Y.

Brain Res. 2019 Jan 1;1702:74-84. doi: 10.1016/j.brainres.2017.09.033. Epub 2017 Oct 10.

PMID:
29030055
8.

The Effect of Head and Neck Radiotherapy on Blood Pressure and Orthostatic Hypotension in Patients With Head and Neck Tumors.

Leibowitz A, Grossman E, Berkovitch A, Levartovski M, Appel S, Sharabi Y, Gluck I.

Am J Hypertens. 2018 Jan 12;31(2):235-239. doi: 10.1093/ajh/hpx158.

PMID:
28985342
9.

Plasma Catechols After Eating Olives.

Goldstein DS, Holmes C, Cherup J, Sharabi Y.

Clin Transl Sci. 2018 Jan;11(1):32-37. doi: 10.1111/cts.12489. Epub 2017 Sep 12.

10.

N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Sharabi Y.

Neurochem Res. 2017 Nov;42(11):3289-3295. doi: 10.1007/s11064-017-2371-0. Epub 2017 Aug 24.

PMID:
28840582
11.

Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91].

Goldstein DS, Sullivan P, Holmes C, Mash DC, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2017 Jun;39:95. doi: 10.1016/j.parkreldis.2017.03.018. Epub 2017 Apr 6. No abstract available.

PMID:
28392299
12.

Is pure autonomic failure a distinct nosologic entity?

Isonaka R, Holmes C, Cook GA Jr, Sullivan P, Sharabi Y, Goldstein DS.

Clin Auton Res. 2017 Apr;27(2):121-122. doi: 10.1007/s10286-017-0412-z. Epub 2017 Mar 16. No abstract available.

PMID:
28303413
13.

Case of Primary Aldosteronism With Discordant Hormonal and Computed Tomographic Findings.

Amar L, Sharabi Y, Rossi GP, Vidal-Petiot E, Dominiczak AF, Mulatero P, Faucon AL, Dhaun N, Touyz RM, Barigou M, Lorthioir A.

Hypertension. 2017 Apr;69(4):529-535. doi: 10.1161/HYPERTENSIONAHA.116.08751. Epub 2017 Feb 13. No abstract available.

PMID:
28193708
14.

Pure autonomic failure without synucleinopathy.

Isonaka R, Holmes C, Cook GA, Sullivan P, Sharabi Y, Goldstein DS.

Clin Auton Res. 2017 Apr;27(2):97-101. doi: 10.1007/s10286-017-0404-z. Epub 2017 Feb 10.

PMID:
28188385
15.

Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy.

Goldstein DS, Sullivan P, Holmes C, Mash DC, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2017 Feb;35:88-91. doi: 10.1016/j.parkreldis.2016.12.011. Epub 2016 Dec 15. Erratum in: Parkinsonism Relat Disord. 2017 Jun;39:95.

16.

Autoimmunity-associated autonomic failure with sympathetic denervation.

Goldstein DS, Holmes C, Sullivan P, Donadio V, Isonaka R, Zhong E, Pourier B, Vernino S, Kopin IJ, Sharabi Y.

Clin Auton Res. 2017 Feb;27(1):57-62. doi: 10.1007/s10286-016-0388-0. Epub 2016 Nov 12.

PMID:
27838780
17.

Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.

Goldstein DS, Holmes C, Sullivan P, Jinsmaa Y, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2016 Oct;31:79-86. doi: 10.1016/j.parkreldis.2016.07.009. Epub 2016 Jul 20.

18.

3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y.

Neurochem Res. 2016 Sep;41(9):2173-8. doi: 10.1007/s11064-016-1959-0. Epub 2016 May 25.

19.

DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells.

Jinsmaa Y, Sullivan P, Sharabi Y, Goldstein DS.

Auton Neurosci. 2016 Jan;194:46-51. doi: 10.1016/j.autneu.2015.12.008. Epub 2015 Dec 31.

20.

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y.

J Pharmacol Exp Ther. 2016 Feb;356(2):483-92. doi: 10.1124/jpet.115.230201. Epub 2015 Nov 16.

21.

Survival in synucleinopathies: A prospective cohort study.

Goldstein DS, Holmes C, Sharabi Y, Wu T.

Neurology. 2015 Nov 3;85(18):1554-61. doi: 10.1212/WNL.0000000000002086. Epub 2015 Oct 2.

22.

Limited reproducibility of 24-h ambulatory blood pressure monitoring.

Keren S, Leibowitz A, Grossman E, Sharabi Y.

Clin Exp Hypertens. 2015;37(7):599-603. doi: 10.3109/10641963.2015.1036065. Epub 2015 Aug 13.

PMID:
26268534
23.

Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, Kopin IJ, Sharabi Y.

Parkinsonism Relat Disord. 2015 Sep;21(9):1013-22. doi: 10.1016/j.parkreldis.2015.07.009. Epub 2015 Jul 17.

24.

Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis.

Shinar Y, Tohami T, Livneh A, Schiby G, Hirshberg A, Nagar M, Goldstein I, Cohen R, Kukuy O, Shubman O, Sharabi Y, Gonzalez-Roca E, Arostegui JI, Rechavi G, Amariglio N, Salomon O.

Orphanet J Rare Dis. 2015 Jun 30;10:86. doi: 10.1186/s13023-015-0298-6.

25.

Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.

Goldstein DS, Sullivan P, Holmes C, Kopin IJ, Sharabi Y, Mash DC.

Parkinsonism Relat Disord. 2015 Jun;21(6):567-72. doi: 10.1016/j.parkreldis.2015.03.006. Epub 2015 Mar 20.

26.

Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.

Goldstein DS, Sullivan P, Cooney A, Jinsmaa Y, Kopin IJ, Sharabi Y.

J Neurochem. 2015 Apr;133(1):14-25. doi: 10.1111/jnc.13042. Epub 2015 Feb 25.

27.

Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.

Goldstein DS, Kopin IJ, Sharabi Y, Holmes C.

Clin Auton Res. 2015 Feb;25(1):61-7. doi: 10.1007/s10286-015-0268-z. Epub 2015 Feb 1.

28.

The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.

Jinsmaa Y, Cooney A, Sullivan P, Sharabi Y, Goldstein DS.

Neurosci Lett. 2015 Mar 17;590:134-7. doi: 10.1016/j.neulet.2015.01.064. Epub 2015 Jan 28.

29.

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Goldstein DS, Kopin IJ, Sharabi Y.

Pharmacol Ther. 2014 Dec;144(3):268-82. doi: 10.1016/j.pharmthera.2014.06.006. Epub 2014 Jun 16. Review.

30.

A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.

Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ.

J Neurochem. 2014 Oct;131(2):219-28. doi: 10.1111/jnc.12766. Epub 2014 Jun 13.

31.

The association between ambulatory systolic blood pressure and cardiovascular events in a selected population with intensive control of cardiovascular risk factors.

Rock W, Leshno M, Shlomai G, Leibowitz A, Sharabi Y, Grossman E.

J Am Soc Hypertens. 2014 Jul;8(7):498-502. doi: 10.1016/j.jash.2014.03.331. Epub 2014 Apr 4.

PMID:
24818617
32.
33.

Serum potassium levels predict blood pressure response to aldosterone antagonists in resistant hypertension.

Shlomai G, Sella T, Sharabi Y, Leibowitz A, Grossman E.

Hypertens Res. 2014 Dec;37(12):1037-41. doi: 10.1038/hr.2014.77. Epub 2014 Mar 27.

PMID:
24671013
34.

Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.

Jinsmaa Y, Sullivan P, Gross D, Cooney A, Sharabi Y, Goldstein DS.

Neurosci Lett. 2014 May 21;569:27-32. doi: 10.1016/j.neulet.2014.03.016. Epub 2014 Mar 23.

35.

Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome.

Eizenberg Y, Grossman E, Peleg E, Shabtai Z, Sharabi Y.

J Am Soc Hypertens. 2014 Apr;8(4):227-31. doi: 10.1016/j.jash.2014.01.006. Epub 2014 Jan 24.

PMID:
24560177
36.

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.

Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y.

J Neurochem. 2013 Sep;126(5):591-603. doi: 10.1111/jnc.12345. Epub 2013 Jul 22.

37.

Normal adiponectin levels in kidney transplant patients with hypertension.

Leibowitz A, Peleg E, Ben-David A, Sharabi Y, Kamari Y, Holzman E, Grossman E.

Clin Transplant. 2013 Jul-Aug;27(4):562-6. doi: 10.1111/ctr.12169. Epub 2013 Jun 13.

PMID:
23758483
38.

Effects of allicin on cardiovascular risk factors in spontaneously hypertensive rats.

Elkayam A, Peleg E, Grossman E, Shabtay Z, Sharabi Y.

Isr Med Assoc J. 2013 Mar;15(3):170-3.

39.

Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment.

Rachmut IH, Samuels N, Melnick SJ, Ramachandran C, Sharabi Y, Pavlovsky A, Maimon Y, Shoham J.

Onco Targets Ther. 2013 Apr 24;6:437-45. doi: 10.2147/OTT.S42038. Print 2013.

40.

Management of the unholy trinity diabetes-obesity-hypertension (diabesotension).

Sharabi Y.

Diabetes Metab Res Rev. 2012 Nov 20. doi: 10.1002/dmrr.2371. [Epub ahead of print]

PMID:
23169567
41.

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.

Goldstein DS, Sullivan P, Cooney A, Jinsmaa Y, Sullivan R, Gross DJ, Holmes C, Kopin IJ, Sharabi Y.

J Neurochem. 2012 Dec;123(6):932-43. doi: 10.1111/j.1471-4159.2012.07924.x. Epub 2012 Oct 25.

42.

Thiazide-induced hyponatremia is predictable.

Grossman E, Sharabi Y, Messerli FH.

Am J Med. 2012 Aug;125(8):e9; author reply e11-2. doi: 10.1016/j.amjmed.2011.12.021. No abstract available.

PMID:
22840677
43.

Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.

Goldstein DS, Holmes C, Sharabi Y.

Brain. 2012 Jun;135(Pt 6):1900-13. doi: 10.1093/brain/aws055. Epub 2012 Mar 26.

44.

Orthostatic hypotension is associated with nocturnal change in systolic blood pressure.

Voichanski S, Grossman C, Leibowitz A, Peleg E, Koren-Morag N, Sharabi Y, Shamiss A, Grossman E.

Am J Hypertens. 2012 Feb;25(2):159-64. doi: 10.1038/ajh.2011.191. Epub 2011 Oct 20.

PMID:
22012209
45.

Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.

Goldstein DS, Bentho O, Park MY, Sharabi Y.

Exp Physiol. 2011 Dec;96(12):1255-61. doi: 10.1113/expphysiol.2010.056259. Epub 2011 Sep 2. Review.

46.

Pheochromocytoma: progress and challenges.

Sharabi Y.

Isr Med Assoc J. 2011 May;13(5):304-5. No abstract available.

47.

Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.

Goldstein DS, Holmes C, Sewell L, Park MY, Sharabi Y.

Clin Auton Res. 2012 Feb;22(1):57-61. doi: 10.1007/s10286-011-0136-4. Epub 2011 Jul 28.

48.

Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases.

Goldstein DS, Holmes C, Kopin IJ, Sharabi Y.

J Clin Invest. 2011 Aug;121(8):3320-30. doi: 10.1172/JCI45803. Epub 2011 Jul 25.

49.

Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.

Sharabi Y, Goldstein DS.

J Neurol Sci. 2011 Nov 15;310(1-2):123-8. doi: 10.1016/j.jns.2011.06.047. Epub 2011 Jul 16.

50.

Autonomic dysfunction in PD: a window to early detection?

Goldstein DS, Sewell L, Sharabi Y.

J Neurol Sci. 2011 Nov 15;310(1-2):118-22. doi: 10.1016/j.jns.2011.04.011. Epub 2011 May 6. Review.

PMID:
21529844

Supplemental Content

Loading ...
Support Center